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Abstract
The suprachiasmatic nucleus (SCN) is a circadian oscillator and biological clock. Cell-to-cell
communication is important for synchronization among SCN neuronal oscillators and the great
majority of SCN neurons use γ-aminobutyric acid (GABA) as a neurotransmitter, the principal
inhibitory neurotransmitter in the adult central nervous system. Acting via the ionotropic GABAA
receptor, a chloride ion channel, GABA typically evokes inhibitory responses in neurons via Cl−
influx. Within the SCN GABA evokes both inhibitory and excitatory responses although the
mechanism underlying GABA-evoked excitation in the SCN is unknown. GABA-evoked
depolarization in immature neurons in several regions of the brain is a function of intracellular
chloride concentration, regulated largely by the cation-chloride cotransporters NKCC1 (for chloride
entry) and KCC1-4 (for chloride egress). It is well established that changes in the expression of the
cation-chloride cotransporters through development determines the polarity of the response to
GABA. To understand the mechanisms underlying GABA-evoked excitation in the SCN, we
examined the SCN expression of cationchloride cotransporters. Previously we reported that the K+/
Cl− cotransporter KCC2, a neuron-specific chloride extruder conferring GABA's more typical
inhibitory effects, is expressed exclusively in vasoactive intestinal peptide (VIP) and gastrin-
releasing peptide (GRP) neurons in the SCN. Here we report that the K+/Cl− cotransporter isoforms
KCC4 and KCC3 are expressed solely in vasopressin (VP) neurons in the SCN whereas KCC1 is
expressed in VIP neurons, similar to KCC2. NKCC1 is expressed in VIP, GRP and VP neurons in
the SCN as is WNK3, a chloride-sensitive neuron-specific serine-threonine kinase which modulates
intracellular chloride concentration via opposing actions on NKCC and KCC cotransporters. The
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heterogeneous distribution of cation-chloride cotransporters in the SCN suggests that Cl− levels are
differentially regulated within VIP/GRP and VP neurons. We suggest that GABA's excitatory action
is more likely to be evoked in VP neurons that express KCC4.
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The hypothalamic suprachiasmatic nucleus (SCN) is a circadian oscillator which functions as
a biological clock (Hastings et al. 2003; Herzog, 2007; Pickard and Sollars, 2008). The SCN
generates an endogenous rhythm in neural activity in the absence of external temporal cues
with action potential firing rate high during the subjective day and low during the subjective
night (Brown and Piggins, 2007). Many SCN neurons function as autonomous oscillators and
cell-to-cell communication is responsible for synchronization among neuronal oscillators and
between sub-regions within the SCN (Welsh et al. 1995; Yamaguchi et al. 2003; Quintero et
al. 2003; Herzog et al. 2004; Albus et al. 2005; Aton and Herzog, 2005). The majority of SCN
neurons contain γaminobutyric acid (GABA) and express glutamate decarboxylase, a key
enzyme of GABA synthesis (Moore and Speh, 1993; Belenky et al. 1996, 2008; Castel and
Morris, 2000). Most synaptic terminals within the mammalian SCN are GABAergic (van den
Pol, 1986), SCN neurons are interconnected by GABAergic synapses (Strecker et al. 1997),
and both GABAA and GABAB receptors are widely, although unevenly, distributed throughout
the SCN (Gao et al. 1995; Belenky et al. 2003, 2008). GABA appears to play an important role
in intra-SCN network activity and synchronization of firing rhythms among SCN neurons (Liu
and Reppert, 2000; Shirakawa et al. 2000; Albus et al., 2005) although it has also been reported
that GABA signaling is not required for synchronization among SCN neurons (Aton et al.
2006).
Although GABA is typically considered an inhibitory neurotransmitter in the adult nervous
system, GABA has been reported to evoke excitatory responses in the SCN. Wagner and
colleagues (1997) first reported a day/night difference in GABA's action in the SCN with
GABA decreasing firing frequency during the subjective night but increasing firing frequency
during the subjective day. Whereas some investigators have reported only inhibitory effects of
GABA in the SCN at all phases of the circadian cycle (Gribkoff et al. 1999; 2003), others have
reported nocturnal excitatory effects of GABA (De Jeu and Pennartz, 2002). Albus and co-
workers (2005) reported excitatory responses to GABA in the SCN but with a much higher
incidence of GABA-evoked excitation in the dorsal as compared to the ventral SCN and these
responses were more evident during the late day/early night. In a recent study by Choi and
colleagues (2008), most GABA-evoked responses observed in the SCN were inhibitory but
some GABA-mediated excitation was observed in both the dorsal and ventral SCN irrespective
of the time of day. However, GABA-evoked excitatory responses were most commonly
observed during the night in the dorsal SCN region (Choi et al. 2008). There is growing
consensus that GABA can evoke excitatory responses in mature SCN neurons, however it
remains unclear if these responses are restricted to particular phases of the circadian cycle and/
or to particular cell types or sub-regions of the nucleus.
The cellular mechanisms underlying GABA-evoked excitation in the SCN are unknown. It is
well documented that GABA acts as an excitatory neurotransmitter early in the development
of the central nervous system (Payne et al. 2003; Ben-Ari et al. 2007). The ionotropic
GABAA receptor is a Cl− channel that opens upon GABA binding. In immature neurons,
GABAA receptor-mediated responses are depolarizing and facilitate the generation of Na+ and
Ca2+ currents whereas later during development and in mature neurons, GABAA receptor-
mediated responses are hyperpolarizing. The shift in GABAergic responses during
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development is related to the expression and function of cation-chloride cotransporters (Rivera
et al., 1999).
Electroneutral in nature, cation-chloride cotransporters do not generate any current but rather
contribute to the inwardly or outwardly directed net flux of ions generated by gradients that
are set by active transporters such as Na+/K+-ATPase. Thus the neuronal K+ gradient is
employed by the K+/Cl− cotransporter (KCC) to extrude Cl− from the cell whereas the Na+/
K+/2Cl− cotransporters (NKCC) use the neuronal Na+ gradient to increase intracellular Cl−
concentration ([Cl−]i). During early postnatal development, expression of NKCC1 is high,
raising [Cl−]i. As development proceeds, KCC2 expression increases, lowering intracellular
Cl− resulting in the characteristic inhibitory responses to GABA (Rivera et al. 1999; Payne et
al. 2003).
It has been suggested that [Cl−]i may be dynamically regulated within the SCN (Wagner et al.
1997, 2001) and a circadian rhythm in [Cl−]i has been reported in acutely dissociated SCN
neurons (Shimura et al. 2002). The role of cation-chloride cotransporters in regulating [Cl−]i
in the mammalian SCN has only recently begun to be examined. Using in situ hybridization,
mRNA expression for two of the four known isoforms of the K+/Cl− cotransporter, KCC1 and
KCC2 were localized to the ventrolateral SCN (Kanaka et al. 2001). KCC2 is neuron specific
and is thought to be the main chloride extruder in the nervous system whereas KCC1 is widely
expressed in different tissues and is considered to be a “housekeeping” transporter (Hebert et
al. 2004). KCC2 protein was subsequently shown to be expressed exclusively in vasoactive
intestinal peptide (VIP) and gastrin-releasing peptide (GRP) neurons located in the ventral and
ventrolateral SCN; no KCC2 was observed in neurons expressing vasopressin (VP) (Belenky
et al. 2008). KCC4 mRNA has also been described in the SCN whereas the same study found
no evidence for KCC3 expression in the SCN (Le Rouzic et al. 2006).
In the present study using immunocytochemical procedures at both the light and electron
microscopic level of examination, we describe the distribution of KCC4, KCC3 and KCC1 in
the SCN. In addition we examine the distribution of NKCC1, a chloride cotransporter
responsible for Cl− influx, and WNK3, a chloride-sensitive protein kinase that modulates
cellular Cl− flux by altering the phosphorylation state of cation-chloride cotransporters (Kahle
et al. 2008). To define more precisely the cellular localization of these proteins within the SCN,
double-label immunocytochemical experiments were conducted to determine whether the
cotransporters were expressed in a cell-type specific manner in association with VIP, GRP, or
VP neurons.
EXPERIMENTAL PROCEDURES
Animals and tissue preparation
Thirty two adult male rats of the Sprague-Dawley strain (Harlan Israel, Jerusalem) were used
for light and electron microscopic immunocytochemical analysis of chloride transporters in
the SCN. Animals were housed in cages with food and water available ad libitum and
maintained under a 12 h light:12 h dark cycle with lights on at 07:00 h. To analyze transporter
expression at different stages of the light/dark cycle, a group of rats (n= 5) was maintained
under an inverted day/night cycle with lights on at 19:00 h; all animals were killed between
11:00 and 13:00 h. All procedures used in the study adhered to guidelines approved by the
Hebrew University of Jerusalem Animal Care and Use Committee and conform to National
Institutes of Health (USA) guidelines. All possible efforts were made to minimize animal
suffering and the number of animals used.
Prior to fixation, rats were deeply anaesthetized with pentobarbital (40 mg/kg) ip. After opening
the thorax, approximately 100 μl of heparin (5000 IU/ml; Choay, Paris, France) were injected
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into the left cardiac ventricle, followed by transcardiac perfusion with phosphate buffered
saline (PBS) (0.1 M phosphate buffer (PB) containing 0.9% sodium chloride; pH 7.4) and then
by perfusion with 300 ml of freshly prepared fixative containing either 4% paraformaldehyde
(PFA) or 4% PFA solution enriched with 0.25% glutaraldehyde (both from Electron
Microscopy Sciences, Fort Washington, PA) in 0.1 M PB. Brains were dissected, trimmed and
stored in the same fixative for an additional four-five hours at room temperature (RT). The
brains were serially sectioned in the coronal plane with a Vibratome (Technical Products
International, St. Louis, MO) at 30 or 50 μm for light and electron microscopy, respectively,
and sections through the SCN region were collected in ice-cold PBS.
Colchicine injections—To increase accumulation of neuropeptides and chloride
cotransporter proteins within SCN cells, rats (n=9) were anaesthetized with sodium
pentobarbital (40 mg/kg) ip, placed into a BenchMark Angle One stereotaxic instrument
(myNeuroLab.com, St. Louis, MO), and prepared for aseptic surgery. A metal cannula
connected via a plastic tube to a 10 μl Hamilton syringe (Hamilton, Reno, NV) was used to
inject 10 μl of colchicine solution (10 μg/μl in 0.9 % saline; Sigma, St. Louis, MO) into the
lateral ventricle (stereotaxic coordinates relative to bregma with skull flat: anteroposterior,
−1.2 mm; medio-lateral, +1.4 mm; dorsoventral, −3.4 mm from the top of the skull) and animals
were killed 24 to 48 hours later.
Immunocytochemistry
Antibody sources—A variety of antibodies was used in this study to detect chloride
cotransporters and associated molecules and to determine the peptidergic nature of the neurons
in which they were expressed. A compilation of antibodies used is presented in Table 1.
Light microscopic immunocytochemistry—For light microscopic immunoperoxidase
and immunofluorescence labeling, free-floating 30 μm thick vibratome sections were pre-
treated with 0.3% H2O2 in PBS (15 min; for sections intended for immunoperoxidase labeling
and tyramide signal amplification only) to inactivate endogeneous peroxidases. In the case of
antibodies against NKCC1, the samples were then treated with 1% SDS (sodium dodecyl
sulfate) in PBS containing 8% 2-mercaptoethanol (5 min, RT). For KCC3 antigen retrieval,
vibratome sections were treated with 20 μg/ml proteinase K in PBS containing 1% BSA for 4
min at 37° C and then after washes in PBS, with SDS/mercaptoethanol mixture as described
above (Person et al. 2001). Finally, after thorough washing in PBS, the sections were incubated
in a blocking solution (5% normal goat or donkey serum, 2% egg albumin, 0.5% glycine, 0.5%
lysine in PBS, 1h at RT) followed with a primary antibody diluted in PBS containing 1% normal
goat or donkey serum and 0.5% egg albumin. Subsequently, 0.3% Triton X-100 was added
both to the blocking solution and the primary antibody solution, and the samples were incubated
for 24-48 h at RT. After thorough washing in PBS the samples were incubated in for 90 min
at RT in an appropriate secondary antibody: either biotinylated IgG (1:500; Vector
Laboratories, Burlingame, CA) or IgG conjugated with AlexaFluor 488 or AlexaFluor 594
(1:500; Molecular Probes, Eugene, OR), or Cy2 and Cy3 (1:300, Jackson ImmunoResearch
Laboratory, West Grove, PA). In the case of immunoperoxidase labeling, this step was
followed with a treatment with ABC solution (ABC Elite kit; Vector Laboratories) and 3,3′-
diaminobenzidine tetrahydrochloride (DAB, 5mg/20 ml PBS with 4 μl of H2O2) as the
chromogen.
In many cases, the intensity of fluorescent signal was increased using Renaissance TSA
fluorescence tyramide signal amplification kit (NEL 704; Perkin Elmer, Boston, MA). Briefly,
after thorough washing in PBS following incubation with the primary antibody, the sections
were incubated in an appropriate biotin-conjugated secondary antibody (either from Vector
Laboratories, Burlingame, CA, 1:600 or from Jackson ImmunoResearch Laboratory, 1:1000),
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then in streptavidin conjugated to horseradish peroxidase (HRP, 1:100) and finally in tyramide
amplification reagent conjugated to Cy3 (up to 10 minutes, RT).
For double immunostaining, free-floating sections through the SCN were incubated in a
cocktail of the primary antibodies, each raised in a different species. Secondary antibodies used
in double-immunolabeling experiments were always generated in the same species, either
affinity-purified donkey or affinity-purified goat antibodies which exhibit minimal cross-
reaction to serum proteins of several species. Additionally, the absence of cross-reactivity
between the secondary antibodies was verified by omitting one of the primary antibodies.
Secondary antibodies used in this case were conjugated to either AlexaFluor 488 or AlexaFluor
594. In many cases one of immunoreactivities was subjected to signal amplification using a
tyramide kit as described above. It proved important to carry out amplification steps
(streptavidin-HRP and tyramide-Cy3 incubations) at the end of the staining protocol to exclude
problems that may have arisen with penetration into the sections of the second secondary
antibody used for “direct” labeling. In rare cases when both primary antibodies were raised in
the same species (e.g. KCC2/KCC4 immunostainings), the method of Shindler and Roth
(1996) was applied in which sequential labeling of the samples is performed; one of the primary
antibodies is used at a dilution approximately ten times higher than is normally used for
immunodetection followed with tyramide signal amplification, and then the second antigen
was labeled using a conventional immunofluorescence staining protocol with second primary
antibody diluted normally. The following steps were used: 1) incubation in the first primary
antibody (anti-KCC2 1:7500, overnight, RT), 2) biotinylated goat anti-rabbit IgG (2 h, RT);
3) incubation in the second primary antibody (anti-KCC4, 1: 1000, overnight, RT); 4) goat-
anti rabbit IgG conjugated with AlexaFluor 488 (1:1000, 2 h); 5) streptavidin-HRP (1:100)
and goat-anti rabbit IgG conjugated with AlexaFluor 488 (45 min); 6) tyramide-Cy3 (1:100,
up to 10 min). The samples were mounted on subbed slides and those intended for fluorescence
microscopy were coverslipped with Vectashield mounting medium (Vector Laboratories).
Pre-embedding HRP immunocytochemistry for electron microscopy—
Immunolabeling at the electron microscopic level was performed using free-floating sections
according to the protocol described earlier (Belenky et al., 2008). Briefly, after mild treatment
with H2O2 (0.015% in PBS, 15 min; only for samples intended for immunoperoxidase labeling
and tyramide signal amplification), sections were cryoprotected with a sucrose/glycerol
mixture. They were then frozen in liquid nitrogen-cooled isopentane (2-methylbutane, Sigma,
St. Louis, MO) and then in liquid nitrogen (60 sec each) and thawed in PBS. The samples were
then incubated in a blocking solution (1h), primary antibody (24 h at RT) and then subjected
to a routine immunoperoxidase labeling procedure as described earlier while the amount of
Triton X-100 both in the blocking solution and the primary antibody was reduced to a maximum
of 0.03%. After thorough washing in PBS the samples were incubated for 2 h at RT in an
appropriate biotinylated secondary antibody (1:500; Vector Laboratories, Burlingame, CA).
This step was followed with a treatment with ABC solution (ABC Elite kit; Vector
Laboratories) and DAB (5mg/20 ml PBS with 4 μl of H2O2) as the chromogen. In some cases
(e.g. NKCC1 or WNK3 immunodetection), tyramide signal amplification was included in the
standard electron microscopic protocol: after the incubation in ABC solution, the vibratome
sections were treated for 10 min at RT with tyramide conjugated to biotin and then again with
ABC reagent and finally with DAB. In many cases the HRP reaction product, visualized using
DAB as the chromogen, was further enhanced and substituted with silver/gold particles (see
Belenky et al., 2008 for details). Briefly, immunostained sections were thoroughly washed in
2% sodium acetate solution and then incubated for 15 min at 60° C in a solution containing
2.6% hexamethylene tetramine, 0.2% silver nitrate, and 0.2% borax. After thorough rinsing,
the sections were treated with 0.05% HAuCl4 solution for 5 min at room temperature and after
further washing in sodium acetate, were incubated in a 1% Na2S2O3 solution to remove the
unbound silver ions.
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Pre-embedding immunogold-silver labeling—This technique was used for detection
of KCC2, KCC4 and WNK3 immunoreactivities as well as VP and VIP in the SCN. Vibratome
cut sections were incubated in the primary antibodies as described above. After rinsing in PBS,
the sections were placed in a blocking solution containing 0.5% BSA and 0.1% cold water fish
gelatin in PBS (15 min, at RT) and then transferred to donkey anti-rabbit IgG or anti-mouse
IgG Fa,b' fragments or goat-anti guinea pig IgG all conjugated to UltraSmall colloidal gold
(Aurion, Wageningen, The Netherlands) diluted 1:90 with BSA/gelatin/PBS (6 h at room
temperature or overnight at 4° C). Gold particles were enlarged for microscopic examination
with the Aurion R-Gent SF-EM silver enhancement kit (90 min at 20° C). Finally, the samples
were postfixed in 2.5% glutaraldehyde in PB, thoroughly washed with PBS and then with
sodium acetate solution and then were toned with a 0.05% aqueous gold chloride solution (10
min at room temperature under dim light), treated with 1% sodium thiosulfate solution (10
min), and thoroughly washed in sodium acetate solution and then in PBS. In the case of double
labeling with involvement of both pre-embedding immunoperoxidase staining and pre-
embedding immunogold labeling, all steps of immunoperoxidase procedure were carried out
first to exclude sedimentation of HRP reaction product (DAB material) on silver particles.
All SCN samples were then postfixed in a mixture of 1% osmium tetroxide and 1.5% potassium
ferricyanide in 0.1M cacodylate buffer pH 7.0, dehydrated in ascending concentrations of
ethanol and flat-embedded between two sheets of Aclar film (Ted Pella, Redding, CA) in EM-
BED812 (Electron Microscopy Sciences). Ultrathin sections prepared with a Reichert Ultracut
were lightly stained with uranyl acetate and lead citrate.
Post-embedding immunogold labeling—Immunogold staining was used to visualize
GABA immunoreactivity in the SCN samples embedded in epoxy resin and stained previously
for WNK3 immunoreactivity. The staining procedure has been described previously (Belenky
et al., 2008). Briefly, ultrathin sections collected on nickel grids were incubated in saturated
aqueous sodium m-periodate (45 min), thoroughly washed in Tris buffered saline (TBS, pH
7.4) containing 0.85% NaCl, 0.5% BSA, 0.13% sodium azide and 0.5% Tween20, and then
placed in 2% egg albumin in TBS as blocker. In some cases, to exclude “washing out” of silver/
gold particles after the preceding pre-embedding staining (for WNK3), pretreatment with m-
periodate was omitted from the protocol (Renno, 2001). Then the sections were incubated in
the primary antibody diluted in TBS containing 0.5% egg albumin for at least 5 hr at room
temperature or overnight at 4° C, followed by goat or donkey anti-rabbit IgG conjugated to 12
nm gold particles (1:10; 90 min, RT; Jackson ImmunoResearch Laboratory). Finally, the
sections were postfixed in 2% aqueous glutaraldehyde (10 min) and contrasted as described
above. Specificity of immunostaining was detected using samples incubated in pre-adsorbed
antibodies (10-40 μg/ml; 48 h at 4° C) or in the vehicle with omission of the primary antibodies.
Non-specific binding was negligible in all cases.
The specificity of immunolabeling for chloride transporters and WNK3 was verified at both
the light and electron microscopic levels by either increasing dilutions of the primary
antibodies, by omitting the primary antibody, or by incubation in the primary antiserum
preadsorbed with an excess of the specific peptide used as immunogen for raising the primary
antibody (10-40 μg/ml, 48 h at 4°C). These experiments led to complete elimination of the
immunostaining in all cases.
Microscopy and analysis
Light microscopic images were captured using an Axioskop-2 microscope (Zeiss, Oberkochen,
Germany) equipped with a cooled KX-85 CCD camera (Apogee Instruments, Tucson, AZ).
Immunofluorescence material was then examined using an Olympus FluoView 1000 confocal
microscope equipped with an argon ion laser (excitation at 488 nm) and a He/Ne laser
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(excitation at 533 nm). Sequential 1 μm optical sections were collected at 505-525 nm and
560-620 nm for green and red channels, respectively. They were stored as 512- × 512-pixel or
1024- × 1024-pixel images. Unambiguous identification of double-fluorescent neurons was
achieved by analysis of several confocal planes through the same structure. Digital images
were pseudo-colored and enhanced for brightness/contrast using Image-Pro Plus software,
version 5.1 (Media Cybernetics, Silver Spring, MD). Confocal images are presented either as
a stack of optical sections or more often as single optical sections.
Ultrathin sections were viewed in Tecnai-12 (Philips) electron microscope equipped with a
MegaView II CCD camera and AnalySIS software version 3.0 (Soft Imaging System, Munster,
Germany). All photomicrographs were unaltered except for brightness/contrast enhancement.
RESULTS
KCC4 is associated with VP neurons in the SCN
Robust labeling for KCC4, one of the four K+/Cl− cotransporter isoforms responsible for
chloride extrusion from cells, was observed in the SCN using a well-characterized rabbit
polyclonal antibody (Karadsheh et al. 2004) and confocal microscopy. KCC4 staining appeared
relatively more intense in SCN neuronal perikarya compared to processes intermingled
amongst the labeled perikarya (Fig. 1a). Double-labeling of SCN sections with KCC4 and VP
antibodies revealed that throughout the SCN KCC4 immunostaining is associated exclusively
with VP-containing profiles (Fig. 1e). In the central and especially more caudal aspects of the
SCN, some VP cells are located in the ventral area of the nucleus outside of the dorsomedial
region considered to be the primary site of VP neurons, and occasionally VP neurons are
observed in close proximity to the optic chiasm. Nevertheless, these VP cells were also
intensely labeled for KCC4; all VP cells were KCC4 positive indicating that expression of
KCC4 is neuron-type specific in the SCN (Fig. 1e). Although the extent of co-localization
appears variable in the 1 μm optical sections presented in Figure 1e, all VP cells were KCC4
positive. No co-localization was detected when SCN sections were double stained with
antibodies against KCC4 and either VIP or GRP (data not shown). Taken together with our
previous finding that the neuron-specific K+/Cl− isoform KCC2 is associated only with VIP
and GRP neurons in the SCN (Belenky et al. 2008), the data suggest that KCC2 and KCC4 are
differentially expressed between the two major SCN neuropeptide populations (i.e., VIP/GRP
and VP).
To test directly that KCC4 and KCC2 are differentially localized in SCN neurons, sections
were double-labeled for KCC4 and KCC2. No co-localization was observed in these
experiments confirming that the two K+/Cl− isoforms are associated with different structures
in the SCN (Figs. 1a-d). Thus, it appears that KCC2 is found exclusively in VIP and GRP
neurons whereas KCC4 is expressed only in VP neurons in the SCN.
At the electron microscopic level (using pre-embedding immunoperoxidase labeling followed
by silver/gold substitution or pre-embedding immunogold staining), labeling for the KCC4
cotransporter was observed predominately, although not exclusively, in the dorsomedial SCN
region, in agreement with the light microscopic observations. In the SCN, KCC4
immunolabeling was detected in numerous perikarya and thin dendritic profiles whereas no
axonal structures were labeled. Immunoreaction product was associated with the cisternae of
rough endoplasmic reticulum and occasional labeling was also detected along the plasma
membrane (Figs. 2a,b). The co-expression of VP and KCC4 observed using confocal
microscopy (Fig.1e) was confirmed at the electron microscopic (data not shown). Thus, in the
rat SCN, KCC4 is expressed only in VP neurons and all VP neurons express KCC4.
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KCC3 is associated with VP neurons in the SCN
To determine the pattern of KCC3 expression in the SCN, we used a well-characterized KCC3
affinity-purified antibody in combination with an antigen retrieval procedure based on
proteinase K (Pearson et al. 2001). This approach revealed unambiguous KCC3
immunoreactivity in the SCN with the staining predominately within perikarya of SCN
neurons; immunopositive neuronal processes were observed to a much lesser extent (Figs.
3a,d). Double-label experiments with antibodies against KCC3 and VP revealed distinct
expression of both antigens in the same cells (Figs. 3a-f). In addition there was clear KCC3
labeling of ependymal cells lining the surface of the third ventricle as well as some neuronal
perikarya and fiber profiles located between the ependymal layer and the SCN proper. No
electron microscopic immunocytochemical analysis was performed for KCC3 due to
incompatibility of the KCC3 antigen retrieval procedure with ultrastructural preservation of
the tissue.
KCC1 expression is similar to that of KCC2 in the SCN
Immunofluorescence confocal microscopic analysis using a well-characterized antibody
directed against a C-terminus fragment of KCC1 (Su et al. 1999; Roussa et al. 2002) revealed
a very distinct pattern of immunolabeling in the SCN (Fig. 1f). In the ventral region, KCC1
immunolabeling was extremely prominent whereas the dorsal SCN exhibited a low level of
immunostaining with only individual KCC1-immunoreactive fibers noted that appeared to
traverse the region. Double staining experiments revealed no expression of KCC1 in VP
neurons whereas KCC1 was expressed in VIP positive profiles. Additionally, KCC1
immunoreactivity was detected in the ependymal cells of the third ventricle as well as in
structures located between the SCN proper and the ependymal cell layer lining the third
ventricle (data not shown). Overall the expression of KCC1 in the SCN is very similar to that
of KCC2 (Fig. 1b, c) with the exception of ependymal cell involvement characteristic only of
KCC1.
NKCC1 is expressed in neurons throughout the SCN
The distribution of the Na+/K+/2Cl- cotransporter NKCC1 in the SCN was examined with two
different antibodies. The general pattern of labeling observed in the SCN was similar with both
antibodies although some differences were noted; the rabbit antibody (code NKCC11a, Alpha
Diagnostic) showed labeling primarily of neuronal perikarya whereas the antibody produced
in chicken, (code ab37792, Abcam) stained both cells and fiber profiles equally well.
At the light microscopic level, with pre-embedding immunoperoxidase labeling using the
rabbit NKCC1 antibody, immunoreactivity was more intense in dorsal and dorsomedial areas
of the nucleus, regions of the SCN normally occupied by VP neurons. NKCC1 labeling of VP
neurons was subsequently confirmed by examination of images captured from SCN sections
stained first for VP using an immunofluorescence approach (Fig. 4a) and then for NKCC1
using immunoperoxidase labeling (Fig. 4b). When the chicken NKCC1 antibody was used in
a double-label paradigm and analyzed by confocal immunofluorescence microscopy, NKCC1
label observed in the SCN was principally associated with perikarya of VP neurons and to a
much lesser extent with dendrite-like profiles (Figs. 5a-c). In the ventral SCN the
predominately perikaryal expression of NKCC1 that is characteristic of VP neurons, was less
apparent; NKCC1 immunostaining in the ventral SCN was more often observed as numerous
discrete puncta or fiber-like profiles (Fig. 6). High magnification confocal images captured
from SCN sections double-stained for NKCC1 and VP, VIP or GRP showed that the chloride
cotransporter was expressed in neuropeptide immunopositive neurons (Figs. 5c-e; 7c).
However, because co-expression of the neuropeptides and NKCC1 was evaluated one
neuropeptide at a time, there were always NKCC1 immunopositive cells that were not labeled
with the peptide being examined. Colchicine pre-treatment of the animals resulted in an
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increase in the intensity of immunostaining both for the chloride cotransporter and the
neuropeptides but colchicine treatment did not change the overall pattern of immunolabeling.
NKCC1 immunoreactivity was also detected in the ependyma lining the third ventricle as well
in the region directly adjacent to the ventricle known to be occupied primarily with numerous
fiber projections and few neuronal perikarya. Thus, NKCC1 is expressed throughout the SCN
and is co-localized with at least VP, VIP, and GRP neurons in the SCN; no additional
neuropeptides were examined
NKCC1 alone is responsible for regulating Cl− influx in neurons and thus might play a pivotal
role in determining the action of GABA in the SCN at different phases of the circadian cycle.
Labeling for NKCC1 in the SCN from animals sacrificed 5 h after lights on (Zeitger Time [ZT]
5) (≈ middle of the day) vs animals sacrificed at ZT 17 (≈ middle of the night) did not reveal
robust differences in staining in the SCN (Figs. 6a,b).
At the electron microscopic level (using pre-embedding immunoperoxidase labeling followed
by silver/gold substitution), clear labeling for the NKCC1 chloride cotransporter was observed
throughout the SCN. NKCC1 immunolabeling was detected in the cell somata in association
with the cisternae of rough endoplasmic reticulum and clear labeling was also detected in the
soma and in dendritic profiles along the plasma membrane (Figs. 7a,c). Double-labeling
revealed that NKCC1 was co-localized with KCC4 in SCN neurons (Figs. 2a,b). In addition,
the NKCC1 chloride cotransporter was detected in the ependymal cells lining the bottom of
the third ventricle (Fig. 7b).
WNK3 kinase is expressed in the SCN
In this next set of experiments we examined the SCN for WNK3, a chloride-sensitive serine-
threonine kinase implicated in the regulation of cellular Cl− flux and GABA-induced
depolarization (Kahle et al. 2005, 2008). WNK3 immunolabeling was noted throughout the
SCN in neuronal perikarya and in dendrite-like profiles (Fig. 8a). The pattern of labeling
observed was similar with the two different commercial antibodies used. A double staining
procedure utilizing a combination of anti-WNK3 antibody with VP and VIP antibodies
revealed that this kinase is co-expressed in both types of peptidergic neuron in the SCN (Figs.
8b-g). As in the case of the chloride cotransporters examined, colchicine injection into the
lateral ventricle of experimental animals did not change the pattern of WNK3 expression but
simply increased the intensity of labeling. In addition to the staining of neuronal profiles within
the SCN proper, labeling for WNK3 was also noted in the ependyma of the third ventricle (not
shown).
At the electron microscopic level, labeling for WNK3 was observed in perikarya and in
dendritic profiles of SCN neurons in agreement with the light microscopic analysis. In the cell
somata, WNK3 immunoreaction product was detected over the cisternae of rough endoplasmic
reticulum, over the numerous dense core vesicles and also near the plasma membrane (Fig.
9a). In dendritic profiles the labeling was detected most often in the vicinity of the plasma
membrane especially in the postsynaptic region of synapses (Fig. 9b,c). Double labeling
employing pre-embedding immunoperoxidase staining with silver/gold substitution for WNK3
and post-embedding immunogold staining for GABA revealed that most of the synapses that
WNK3 was associated with were GABAergic (Fig. 9c). Ultrastructural investigation of SCN
sections double stained with antibodies against WNK3 and NKCC1 revealed that both antigens
are co-localized in the vast majority of analyzed cells in the SCN (not shown).
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DISCUSSION
K+/Cl− Cotransporters in the SCN
Potassium/chloride cotransporters convey Cl− out of cells and thus play a major role in
maintaining low neuronal intracellular Cl− levels. Four K-Cl isoforms have been identified and
we provide evidence that their expression is neuron-type specific in the SCN: KCC4 and KCC3
are expressed only in neurons also containing VP whereas KCC2 and KCC1 are found
exclusively in VIP and GRP neurons. The KCC3 isoform of the K+/Cl− cotransporters has not
previously been described in the SCN. Le Rouzic and colleagues (2006) failed to detect KCC3
expression in the rat hypothalamus using antisense riboprobes against the KCC3a splice
variant, which is abundantly expressed in brain (Pearson et al. 2001). A hybridization signal
for KCC4 mRNA has been described for the SCN although the peptidergic signature of neurons
expressing KCC4 was not specified (Le Rouzic et al. 2006). We have previously reported that
KCC2 is expressed in the SCN in a neuron-type specific manner in VIP and GRP neurons
(Belenky et al. 2008). A low level of KCC1 mRNA has been reported in the SCN in the
ventrolateral part of the nucleus, a region normally occupied by VIP and GRP cells, although
the neurochemical identity of the cells expressing KCC1 was not determined; no KCC1 signal
was noted in the dorsomedial SCN sub-region (Kanaka et al. 2001). We extend the findings of
Kanaka and colleagues (2001) by demonstrating that KCC1 is expressed in VIP cells in the
SCN.
Our current results taken together with our previous findings and those of other investigators
provide unambiguous evidence for the differential expression of the K+/Cl− cotransporters in
the SCN. KCC2 and KCC1 are expressed in VIP/GRP neurons whereas KCC4 and KCC3 are
found in VP neurons. Based on the robustness of immunostaining for protein or hybridization
signal for message, KCC2 and KCC4 appear to be the dominant K+/Cl− isoforms in VIP/GRP
and VP neurons, respectively. In other regions of the central nervous system, KCC2 and KCC4
are differentially expressed. In large motor neurons of the spinal cord and brainstem, no KCC4
was detected in the spinal motor neurons that express KCC2 (Hubner et al. 2001) whereas large
motor neurons in the brainstem that contribute to the cranial nerves show strong KCC4
immunoreactivity (Karadsheh et al. 2004). The differential expression of K+/Cl− cotransporters
in functionally similar sets of neurons suggests that Cl− flux may be regulated differently
perhaps to modulate the GABAergic input to these cells.
It may be informative to consider the distribution of the various K+/Cl− cotransporters along
with the expression of GABA and GABA associated receptors (ionotropic GABAA receptors
and metabotropic GABAB receptors) in the SCN. KCC2 and KCC1 are characteristic of VIP
and GRP neurons in the SCN, cells that have a high density of GABA innervation (Belenky
et al. 2008), a high expression of GABAA receptors (Gao et al.1995; Belenky et al. 2003) and
a lack of or low expression of GABAB receptors (Belenky et al. 2008). Conversely, KCC4 and
KCC3 cotransporters in the SCN are characteristic of VP neurons, cells that have a lower
density of GABA innervation and GABAA receptors but a greater number of GABAB receptors
(Belenky et al. 2008).
In addition to the cell-type specific localization for KCC2 and KCC4 in the SCN, the subcellular
distribution of these K+/Cl− cotransporters is also different in VIP and VP cells. In VIP cells,
KCC2 was observed more often in dendritic profiles (Belenky et al. 2008) whereas KCC4 is
more often associated with the plasma membrane of the VP neuronal soma (current study).
The functional significance of the bias for KCC2 dendritic vs KCC4 somal localization in SCN
neurons is presently unknown. However, in the substantia nigra KCC2 is also expressed in a
cell-type specific manner being found in GABAergic but not dopaminergic neurons (Gulácsi
et al. 2003). In GABAergic neurons in the substantia nigra KCC2 is preferentially localized in
the dendritic plasma membrane at the periphery of synapses at the postsynaptic site where the
Belenky et al. Page 10
Neuroscience. Author manuscript; available in PMC 2011 February 17.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
major Cl− load is generated (Gulácsi et al. 2003). Subcellular localization of NKCC1 to the
axon initial segment is responsible for the GABA-evoked depolarization of axo-axonic input
to cortical principal neurons (Khirug et al. 2008) whereas dendritic compartmentalization of
NKCC2 and KCC2 to the proximal and distal dendrites of starburst amacrine cells in the retina
underlies GABA-evoked depolarization and hyperpolarization, respectively (Gavrikov et al.
2006). The prominent dendritic localization of KCC2 in VIP (and GRP) neurons in the SCN
may provide for a more efficient Cl− removal and thus a greater probability that GABA will
evoke an inhibitory response. The cell-specific expression of K+/Cl− isoforms in the SCN
coupled with their different subcellular distribution suggests that Cl− flux might be regulated
differently in these two populations of SCN neurons. As will be discussed below, these
observations may provide a coherent view on the ionic mechanisms regulating GABA-evoked
excitation in the SCN.
The K+/Cl− cotransporters can be parsed into two phylogenic subgroups; KCC2 is paired with
KCC4 whereas KCC1 is more homologous to KCC3 (Mercado et al. 2000; Hebert et al.
2004). KCC2 is a neuronal specific isoform whereas the other three isoforms are widely
distributed (Karadsheh et al. 2001). The KCC2 isoform is also unique in that it mediates
constitutive K+/Cl− cotransport under isotonic conditions whereas the other three K-Cl
isoforms exhibit no apparent isotonic activity (Mercado et al. 2006). Moreover, KCC2 exhibits
a much higher cation affinity than the other three K+/Cl− cotransporters (Hebert et al. 2004).
When KCC1 and KCC4 were compared as representatives of each subgroup, clear functional,
kinetic, and pharmacological differences were revealed when analyzed after expression in
Xenopus oocytes, (Mercado et al. 2000). These differences may have important physiological
implications particularly with regard to cellular volume regulation in non-neuronal tissues. It
remains to be determined exactly how the functional differences between subtypes of K+/
Cl− cotransporters translate into variations of ion flux regulation in neurons. It is however clear
that deficiency of KCC3 and KCC4 can impact intracellular [Cl−] in neurons and epithelial
cells, respectively (Boettger et al. 2002, 2003).
NKCC1 Cotransporter in the SCN
The neuronal transmembrane Cl− gradient is maintained by a combination of Cl− efflux via
the K+/Cl− cotransporters and by Cl− influx regulated by the Na+/K+/2Cl− cotransporter
NKCC1 (Payne et al. 2003). In the current study NKCC1 was observed to be distributed
throughout the SCN in association with VIP, GRP and VP neurons in agreement with Western
blot analysis indicating NKCC1 protein in both the ventral and dorsal regions of the SCN
(Choi et al. 2008). A functional role for NKCC1 in the regulation of [Cl−]i in SCN neurons
comes from pharmacological experiments employing the NKCC1 antagonist bumetanide; after
bumetanide application the reversal potential of evoked EPSPs in SCN neurons shifted
significantly to a more hyperpolarized potential (Choi et al. 2008). Choi and colleagues
(2008) also report a two-fold increase in NKCC1 protein in the dorsal SCN at night (ZT 16)
vs the day (ZT 4) determined from Western blot analysis of SCN sub-regions; our
morphological analysis did not reveal robust differences in NKCC1 immunostaining at ZT 17
compared to ZT 5.
GABA-evoked Excitation in the SCN
GABAA receptor activation in mature neurons typically generates a net influx of Cl− resulting
in hyperpolarization and inhibition. In immature neurons GABA depolarizes and evokes
excitation by gating Cl− efflux (Kaila, 1994). The level of expression of NKCC1 and KCC2
in immature neurons appears to determine [Cl−]i. Rivera and colleagues (1999) reported that
as development proceeds in the hippocampus, KCC2 is up-regulated resulting in a reduction
in [Cl−]i and a reversal of GABA-evoked depolarization to GABA-evoked hyperpolarization.
Thus as the central nervous system matures, either reduced expression/activity of NKCC1 and/
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or increased expression/activity of KCC2 results in low [Cl−]i typical of adult neurons (Rivera
et al. 1999, 2005; DeFazio et al. 2000; Vardi et al. 2000; Hübner et al. 2001; Stein et al.
2004; Zhang et al. 2007; Delpy et al. 2008; Reynolds et al. 2008; Zhu et al. 2008). GABA can
evoke excitatory responses in mature SCN neurons although as described above, the literature
is inconsistent regarding: 1) where in the SCN GABA-evoked excitation is generated; and 2)
the phase of the circadian cycle in which GABA is excitatory. Some of the differences amongst
the studies may be attributed to different recording locations within the SCN which surprisingly
are not reported. In that same regard, based on our description of neuron-type specific
distribution of KCC2 and KCC4, the general location of recording within the SCN may be less
relevant than the specific type of neuron recorded.
Dorsomedial and Ventrolateral SCN Sub-regions and GABA-evoked Excitation
In our study we have intentionally limited the use of the terms dorsomedial and ventrolateral
when describing the distribution of cotransporters in the SCN because the cotransporters are
not regionally distributed per se but rather they are expressed in a cell-type specific manner.
To the extent that specific peptidergic neurons are distributed in a non-homogenous manner,
then such is also the case for the cotransporters. Thus, describing KCC2 as found in the
ventrolateral SCN would be an oversimplification as would be describing KCC4 as localized
to the dorsomedial SCN. If one were sampling these two regions with a recording electrode,
cells expressing KCC4 (or VP) would be more likely to be encountered in the dorsomedial
SCN and cells expressing KCC2 (or VIP) would be more likely to be encountered in the
ventrolateral SCN, but one would still encounter KCC2/VIP neurons in the dorsomedial region
and coming across KCC4/VP cells in the ventral SCN would almost seem likely (see Fig. 3).
If, as we suggest, the differential expression of KCC2 and KCC4 plays a major role in regulating
[Cl−]i, then future studies that describe the specific cell type recorded when examining the
excitatory effects of GABA in the SCN may help explain the present inconsistencies. Even
without the knowledge of the specific cell type recorded, recent work has suggested that
GABA-evoked excitatory responses are more likely to be observed from the dorsal SCN and
during the subjective night (Albus et al. 2005;Choi et al. 2008).
Cl− Cotransporter Regulation
The functional pool of Cl− cotransporters in neurons is dynamically regulated. Regulation of
Cl− cotransporters on a daily basis in the adult SCN could represent a recapitulation of the
developmental process of transcriptional regulation of Cl− cotransporters. An E-box control
element has been identified in the promoter of the KCC2b splice variant (Markkanen et al.
2008). Circadian timing is controlled by interlocked transcriptional feedback loops and DNA
binding of the transcription factors CLOCK and BMAL1 has been shown to involve canonical
E-box sequences (Takahashi et al. 2008).
Kinases appear to play a major role in the regulation of Cl− cotransporter functional activity
and kinase activity in the SCN could be temporally controlled. Phosphorylation of Cl−
cotransporters appears to be regulated at least in part by the novel serine-threonine kinase WNK
that has a unique substitution of cysteine for lysine at a nearly invariant position in the catalytic
core (hence with no K [lysine]) (Kahle et al. 2008). Phosphorylation by the WNK3 isoform
modulates Cl− flux by activating NKCC1 while at the same time WNK3-mediated
phosphorylation inhibits KCC2; dephosphorylation via phosphatase activity has the opposite
effects (Kahle et al. 2005, 2006; del los Heros et al. 2006). In this study we report for the first
time that WNK3 protein is localized within the rat SCN. WNK3 mRNA was previously
reported in the mouse SCN (Kahle et al. 2005). The WNK1 isoform of the WNK kinase is
rhythmically expressed in Arabidopsis thaliana and phosphorylates the APRR3 component of
the clock-associated APRR1/TOC1 quintet (Murakami-Kojima et al. 2002); the WNK gene
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family regulates flowering time in this plant by modulating the photoperiod pathway (Wang
et al. 2008).
The results of the present electron microscopic immunocytochemical investigation of WNK3
provide the first evidence for the strong expression of WNK3 kinase in the postsynaptic region
of axo-somatic and axo-dendritic synapses on neurons located in the SCN. Moreover, the
double-label procedure employing pre-embedding immunoperoxidase labeling with silver/
gold substitution for WNK3 and postembedding immunogold staining for GABA, has revealed
that most of these synapses are GABAergic. As has been shown previously, the postsynaptic
plasma membrane is a region of neurons enriched in GABAA receptors (Fujiyama et al.
2000; Belenky et al. 2003) which themselves are ligand-gated chloride channels (Kaila,
1994). WNK3 kinase may play an important role in detection of the direction of Cl− flux in
SCN neurons and, thus, in the regulation of the excitability of these cells.
The activity of Cl− cotransporters is also regulated by protein trafficking, oligomerization, and
postsynaptic activity. Increased targeting of KCC2 to the neuronal cell surface via PKC-
dependent phosphorylation may play a role in its functional activity (Lee et al. 2007). In
addition, activity-dependent regulation has been described for KCC2; downregulation is rapid,
consistent with an alteration in membrane trafficking and/or posttranslational modification
(Fiumelli and Woodin, 2007; Banke and Gegelashvili, 2008; Hewitt et al. 2009). Coincident
pre- and postsynaptic neural activity also has been shown to downregulate NKCC1 (Balena
and Woodin, 2008). Moreover, oligomerization of KCC2 and NKCC1 is important for the
functional activity of the cotransporters in the neuronal plasma membrane (Blaesse et al.
2006; Parvin et al. 2007).
The cellular mechanism(s) underlying GABA's excitatory action in the SCN is not known with
certainty, although regulation of K+/Cl− cotransporter activity seems likely to play an important
role. The ability of GABA's action to switch from inhibitory to excitatory, perhaps in a cell-
type specific manner, may enhance the activity of local sub-circuits within the overall SCN
network. Subtle changes in the functional activity of K+/Cl− cotransporters can have profound
effects on the output of neuronal networks in the hypothalamus (Hewitt et al. 2009). It is clear
that a finer level of analysis of SCN neuron interaction is required to fully understand the
integrated network capacity of this complex and heterogeneous structure that functions as a
biological clock.
Summary
K+/Cl− cotransporters are expressed in a cell-specific manner in the SCN and are distributed
to different cellular compartments in SCN neurons (Fig. 10). Cl− flux may be differentially
regulated in VIP/GRP neurons expressing KCC2/KCC1 and VP neurons expressing KCC4/
KCC3. In addition, Cl− cotransporters may be dynamically regulated in the SCN. The ability
of GABA to evoke excitatory responses in mature SCN neurons may therefore be restricted to
a specific neuronal phenotype providing spatial heterogeneity and loosely correlating with a
dorsomedial/ventrolateral scheme. Temporal regulation of cotransporter activity to specific
phases of the circadian cycle, perhaps via a link to the core transcriptional molecular clock
mechanism, may provide an additional level of regulation of GABA's ability to evoke
excitatory responses in the SCN.
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Abbreviations
BSA bovine serum albumin
[Cl−]i intracellular chloride concentration
DAB 3,3′-diaminobenzidine tetrahydrochloride
GABA γ-aminobutyric acid
GABAA γ-aminobutyric acid receptor A subtype
>GABAB γ-aminobutyric acid receptor B subtype
GRP gastrin releasing peptide
IgG immunoglobulin G
K+/Cl− potassium/chloride
KCC potassium/chloride cotransporter
Na+/K+/2Cl− sodium/potassium/chloride
NKCC sodium/potassium/chloride cotransporter
PBS phosphate buffered saline
PFA paraformaldehyde
RT room temperature
SCN suprachiasmatic nucleus
TBS tris buffered saline
VIP vasoactive intestinal peptide
VP vasopressin
WNK with no lysine
ZT zeitgeber time
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Fig. 1.
Confocal laser microscopy images of sections through the mid-portion of the SCN
demonstrating expression of KCC4, KCC2 and KCC1 as well as vasopressin (VP) and
vasoactive intestinal peptide (VIP). a-c: Images illustrating the expression of KCC4 and KCC2
in different perikarya in the SCN. d: High magnification image of a double-labeled SCN section
stained for KCC2 (red) and KCC4 (green) illustrating lack of co-expression. KCC4 expressing
neurons are marked with asterisks. e: A merged confocal image of a 1 μm optical section of
the SCN double-labeled with antibodies against KCC4 (red) and vasopressin (VP, green). Note
the abundant co-localization of KCC4 immunoreactivity in VP neurons. f: A merged confocal
image 1 μm optical section through the mid-portion of the SCN double-labeled with antibodies
against KCC1 (red) and VIP (green). Note that the pattern of KCC1 expression is very similar
to that of KCC2 illustrated in panels b and c. KCC1 and VIP are co-expressed in many neuronal
profiles. Tyramide signal amplification for KCC2 immunoreactivity in a-d, and tyramide signal
amplification for KCC4 immunoreactivity in e. Single optical slices, 1 μm resolution. Scale
bar = 25 μm in a-c and f, 10 μm in d and 15 μm in e.
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Fig. 2.
Electron micrographs demonstrating co-expression of KCC4 (large gold particles identified
with arrows) and NKCC1 (small gold particles pointed out with arrowheads) in a perikaryon
(a) and a dendritic profile (D in b) of SCN neurons from the dorsomedial SCN. Note that KCC4
cotransporter is mainly expressed in the cytoplasm and only single gold particles are associated
with the plasma membrane (pm). In panel b NKCC1 labeling associated with the plasma
membrane is marked with arrowheads. The adjacent nerve terminal (T in panel a) is not labeled.
Pre-embedding immunogold staining for KCC4 and pre-embedding immunoperoxidase
labeling with silver/gold substitution for NKCC1. Tyramide signal amplification for NKCC1.
Scale bar = 0.2 μm.
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Fig. 3.
Confocal images of the SCN double stained for KCC3 (red; a, d) and vasopressin (VP, green;
b, e). Note that all neuronal perikarya seen in the merged images (c, f) co-express KCC3 and
vasopressin. KCC3 immunoreactivity is also located in the ependyma lining the third ventricle.
For KCC3 antigen retrieval SCN sections were treated with proteinase K followed by
incubation in an SDS/mercaptoethanol mixture (see Person et al., 2001 for details). Single
optical slices with 1 μm resolution. III, third ventricle; OC, optic chiasm. Scale bar = 25 μm
in a-c, and 10 μm in d-f.
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Fig. 4.
Photomicrographs of a section through the mid rostrocaudal region of the SCN double stained
with an antibody against vasopressin (panel a, immunofluorescent technique with AlexaFluor
594) and rabbit anti-NKCC1 antibody (panel b, immunoperoxidase procedure). The latter
antibody more clearly detects NKCC1 associated with neuronal perikarya. Image in panel b
was then pseudocolored to increase the contrast. In animals sacrificed at ZT 5-7 NKCC1
immunoreactivity appears more strongly expressed in the dorsomedial region of the SCN, the
region containing the majority of VPergic neurons (arrows). Asterisk shows a group of VP
neurons located in the lateral part of the nucleus outside of the high density region of VP
neurons. Scale bar = 50 μm.
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Fig. 5.
Confocal images taken from a mid rostrocaudal region of the SCN of a rat injected with
colchicine and immunostained with anti-NKCC1 antibody raised in chicken. Panels a-c
demonstrate coexpression of NKCC1 (red; a) and vasopressin (green; b and merge in c).
Merged images in panels d and e show coexpression of NKCC1 with VIP (d) and GRP (e),
respectively. Asterisks in c, d and e point out the co-labeled neuronal perikarya. Tyramide
signal amplification for NKCC1 immunoreactivity. Single optical slices, 1 μm resolution. Scale
bar = 10 μm.
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Fig. 6.
Confocal images demonstrating expression of NKCC1 in the mid rostrocaudal region of the
SCN from rats sacrificed at ZT5 (panel a) and at ZT17 (panel b). Small insets at the upper left
corner of panels a and b are merged images captured from the same sections showing the
distribution of VP (green in a′ and b′). Note that NKCC1 immunoreactivity is widely expressed
in the SCN and in the dorsomedial subregion it is mainly associated with perikarya of neurons
containing VP while no robust differences were detected in the staining of these cells in the
SCN of rats sacrificed at ZT5 and at ZT17. In the ventral SCN, NKCC1 is not evenly
distributed: the medial part of the ventral SCN known to contain intensely stained VIP
perikarya shows a low level of NKCC1 immunostaining whereas the lateral part of the same
subregion displays abundant, mainly punctuate fluorescence, associated with numerous fibers
(arrows). Tyramide signal amplification for NKCC1 immunoreactivity. III, third ventricle; OC,
optic chiasm. Scale bar = 25 μm.
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Fig. 7.
Electron micrographs showing distribution of NKCC1in the SCN. a: A fragment of a neuron
(N) from the ventral SCN with strong labeling near the plasma membrane and in the cytoplasm.
b: NKCC1 labeling in the apical part of an ependymal cell lining the bottom of the III ventricle.
c: A dendritic profile (D) from a ample double stained for NKCC1 (small gold particles) and
VP (large gold particles). An adjacent nerve terminal (T) is unlabeled. Pre-embedding
immunoperoxidase labeling with silver/gold substitution in a and b, and pre-embedding
immunoperoxidase staining with silver/gold substitution for NKCC1 in combination with pre-
embedding immunogold labeling for VP in c. Tyramide signal amplification for NKCC1
immunoreactivity. Scale bar = 0.2 μm in a and c, and 0.5 μm in b.
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Fig. 8.
Confocal images illustrating the distribution of WNK3, a serine-threonine kinase, in the SCN
of a rat subjected to colchicine treatment. (a) WNK3 is widely distributed throughout the
nucleus although it is more strongly expressed in the dorsomedial subregion. Panels b-d and
e-g demonstrate expression of WNK3 (red) in VP (green) and VIP (green) SCN neurons,
respectively. In panels d and g neurons co-labeled for WNK3 and either VP (d) or VIP (g) are
marked with asterisks. Tyramide signal amplification for WNK3 immunoreactivity. Single
optical slices, 1 μm resolution. III, third ventricle; OC, optic chiasm. Scale bar = 25 μm in a,
and 10 μm in b-g.
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Fig. 9.
Electron micrographs demonstrating sub-cellular distribution of WNK3 kinase in SCN
neurons. a: Within a perikaryon from the ventral SCN, WNK3 immunoreactivity is associated
with the rough endoplasmic reticulum (rer), numerous dense core vesicles (dcv) as well as with
the plasma membrane (arrowheads). b: Two nerve terminals (T) making contact with a dendrite
(D). Note the strong accumulation of WNK3 immunoreactive material near the postsynaptic
membrane (arrowheads). c: A synapse between a GABAergic (large gold particles) nerve
terminal (T) and a GABAergic dendrite (D). Note localized expression of WNK3
immunoreactivity (small gold particles indicated with arrows) near the postsynaptic plasma
membrane. Pre-embedding immunoperoxidase labeling with silver/gold substitution for
Belenky et al. Page 27
Neuroscience. Author manuscript; available in PMC 2011 February 17.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
WNK3 immunoreactivity and postembedding immunogold labeling for GABA. m,
mitochondria; Scale bar a-c = 0.2 μm.
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Fig 10.
KCC2 and KCC4 K-Cl cotransporters are expressed in a cell-specific manner in the rat SCN.
A. Diagrammatic illustration of the neuron-specific distribution of KCC4 (and KCC3) in VP
cells and KCC2 (and KCC1) in VIP/GRP cells in the SCN. The distribution of VP/KCC4 cells
and VIP/KCC2 cells in the SCN produces a general dorsal/ventral division of the two different
K-Cl cotransporters. B. Depiction of the VP and VIP/GRP sub-regions of the SCN. GABAergic
input is greater to the VIP region compared to the VP region and VIP cells express very few
GABAB receptors whereas VP cells heavily express GABAB receptors. The subcellular
distribution of KCC2 in VIP cells differs from that of KCC4 in VP cells. KCC2 is expressed
more heavily in the membrane of dendritic processes of VIP/GRP cells compared to the amount
of cotransporter observed in the membrane of the cell soma. KCC4 is more heavily expressed
in the membrane of the soma of VP cells compared to the level of KCC4 observed in the
membrane of the dendritic processes. VP and VIP/GRP cells express NKCC1 and WNK3 (not
shown).
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